160 related articles for article (PubMed ID: 32220323)
21. exRNAdisease: An extracellular RNA transcriptome atlas in human diseases.
Zhao L; Ning Q; Zheng G; Luo J; Dong D
Gene; 2022 Aug; 836():146662. PubMed ID: 35690280
[TBL] [Abstract][Full Text] [Related]
22. Total Extracellular Small RNA Profiles from Plasma, Saliva, and Urine of Healthy Subjects.
Yeri A; Courtright A; Reiman R; Carlson E; Beecroft T; Janss A; Siniard A; Richholt R; Balak C; Rozowsky J; Kitchen R; Hutchins E; Winarta J; McCoy R; Anastasi M; Kim S; Huentelman M; Van Keuren-Jensen K
Sci Rep; 2017 Mar; 7():44061. PubMed ID: 28303895
[TBL] [Abstract][Full Text] [Related]
23. Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline.
Lantero Rodriguez J; Karikari TK; Suárez-Calvet M; Troakes C; King A; Emersic A; Aarsland D; Hye A; Zetterberg H; Blennow K; Ashton NJ
Acta Neuropathol; 2020 Sep; 140(3):267-278. PubMed ID: 32720099
[TBL] [Abstract][Full Text] [Related]
24. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
25. Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects.
Nagaraj S; Laskowska-Kaszub K; Dębski KJ; Wojsiat J; Dąbrowski M; Gabryelewicz T; Kuźnicki J; Wojda U
Oncotarget; 2017 Mar; 8(10):16122-16143. PubMed ID: 28179587
[TBL] [Abstract][Full Text] [Related]
26. Role of Plasma Clusterin in Alzheimer's Disease-A Pilot Study in a Tertiary Hospital in Northern India.
Vishnu VY; Modi M; Sharma S; Mohanty M; Goyal MK; Lal V; Khandelwal N; Mittal BR; Prabhakar S
PLoS One; 2016; 11(11):e0166369. PubMed ID: 27861589
[TBL] [Abstract][Full Text] [Related]
27. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.
Siedlecki-Wullich D; Català-Solsona J; Fábregas C; Hernández I; Clarimon J; Lleó A; Boada M; Saura CA; Rodríguez-Álvarez J; Miñano-Molina AJ
Alzheimers Res Ther; 2019 May; 11(1):46. PubMed ID: 31092279
[TBL] [Abstract][Full Text] [Related]
28. Blood methylomic signatures of presymptomatic dementia in elderly subjects with type 2 diabetes mellitus.
Lunnon K; Smith RG; Cooper I; Greenbaum L; Mill J; Beeri MS
Neurobiol Aging; 2015 Mar; 36(3):1600.e1-4. PubMed ID: 25585531
[TBL] [Abstract][Full Text] [Related]
29. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Olsson B; Lautner R; Andreasson U; Öhrfelt A; Portelius E; Bjerke M; Hölttä M; Rosén C; Olsson C; Strobel G; Wu E; Dakin K; Petzold M; Blennow K; Zetterberg H
Lancet Neurol; 2016 Jun; 15(7):673-684. PubMed ID: 27068280
[TBL] [Abstract][Full Text] [Related]
30. Serum levels of pregnancy zone protein are elevated in presymptomatic Alzheimer's disease.
Ijsselstijn L; Dekker LJ; Stingl C; van der Weiden MM; Hofman A; Kros JM; Koudstaal PJ; Sillevis Smitt PA; Ikram MA; Breteler MM; Luider TM
J Proteome Res; 2011 Nov; 10(11):4902-10. PubMed ID: 21879768
[TBL] [Abstract][Full Text] [Related]
31. Plasma extracellular RNA profiles in healthy and cancer patients.
Yuan T; Huang X; Woodcock M; Du M; Dittmar R; Wang Y; Tsai S; Kohli M; Boardman L; Patel T; Wang L
Sci Rep; 2016 Jan; 6():19413. PubMed ID: 26786760
[TBL] [Abstract][Full Text] [Related]
32. exRNA-eCLIP intersection analysis reveals a map of extracellular RNA binding proteins and associated RNAs across major human biofluids and carriers.
LaPlante EL; Stürchler A; Fullem R; Chen D; Starner AC; Esquivel E; Alsop E; Jackson AR; Ghiran I; Pereira G; Rozowsky J; Chang J; Gerstein MB; Alexander RP; Roth ME; Franklin JL; Coffey RJ; Raffai RL; Mansuy IM; Stavrakis S; deMello AJ; Laurent LC; Wang YT; Tsai CF; Liu T; Jones J; Van Keuren-Jensen K; Van Nostrand E; Mateescu B; Milosavljevic A
Cell Genom; 2023 May; 3(5):100303. PubMed ID: 37228754
[TBL] [Abstract][Full Text] [Related]
33. RNA-Seq data mining: downregulation of NeuroD6 serves as a possible biomarker for alzheimer's disease brains.
Satoh J; Yamamoto Y; Asahina N; Kitano S; Kino Y
Dis Markers; 2014; 2014():123165. PubMed ID: 25548427
[TBL] [Abstract][Full Text] [Related]
34. The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results.
de Mauléon A; Soto M; Kiyasova V; Delrieu J; Guignot I; Galtier S; Lilamand M; Cantet C; Lala F; Sastre N; Andrieu S; Pueyo M; Ousset PJ; Vellas B
J Prev Alzheimers Dis; 2017; 4(3):183-193. PubMed ID: 29182709
[TBL] [Abstract][Full Text] [Related]
35. Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models enables specific monitoring of tumour-derived extracellular RNA.
Vermeirssen V; Deleu J; Morlion A; Everaert C; De Wilde J; Anckaert J; Durinck K; Nuytens J; Rishfi M; Speleman F; Van Droogenbroeck H; Verniers K; Baietti MF; Albersen M; Leucci E; Post E; Best MG; Van Maerken T; De Wilde B; Vandesompele J; Decock A
NAR Cancer; 2022 Dec; 4(4):zcac037. PubMed ID: 36451702
[TBL] [Abstract][Full Text] [Related]
36. Potential utility of soluble p3-alcadein α plasma levels as a biomarker for sporadic Alzheimer's disease.
Kamogawa K; Kohara K; Tabara Y; Takita R; Miki T; Konno T; Hata S; Suzuki T
J Alzheimers Dis; 2012; 31(2):421-8. PubMed ID: 22571980
[TBL] [Abstract][Full Text] [Related]
37. Plasma Biomarkers: Potent Screeners of Alzheimer's Disease.
Naveed M; Mubeen S; Khan A; Ibrahim S; Meer B
Am J Alzheimers Dis Other Demen; 2019 Aug; 34(5):290-301. PubMed ID: 31072117
[TBL] [Abstract][Full Text] [Related]
38. Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration.
Ashton NJ; Leuzy A; Lim YM; Troakes C; Hortobágyi T; Höglund K; Aarsland D; Lovestone S; Schöll M; Blennow K; Zetterberg H; Hye A
Acta Neuropathol Commun; 2019 Jan; 7(1):5. PubMed ID: 30626432
[TBL] [Abstract][Full Text] [Related]
39. A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.
Wang H; Stewart T; Toledo JB; Ginghina C; Tang L; Atik A; Aro P; Shaw LM; Trojanowski JQ; Galasko DR; Edland S; Jensen PH; Shi M; Zhang J;
J Alzheimers Dis; 2018; 61(4):1541-1553. PubMed ID: 29376878
[TBL] [Abstract][Full Text] [Related]
40. Searching for predictive blood biomarkers: misfolded p53 in mild cognitive impairment.
Stanga S; Lanni C; Sinforiani E; Mazzini G; Racchi M
Curr Alzheimer Res; 2012 Dec; 9(10):1191-7. PubMed ID: 22746246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
